Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, March 2000, p. 197-199, Vol. 7, No. 2
Division of AIDS, STD, and TB Laboratory Research, Centers
for Disease Control and Prevention, Atlanta, Georgia 30333
Received 13 August 1999/Returned for modification 4 November
1999/Accepted 29 December 1999
The efficacy of lipid removal from human serum samples obtained by
using Cleanascite HC, a commercially available product, was compared to
that obtained by the standard chloroform method. Separate samples of 21 frozen, banked human serum samples used in the preparation of samples
for proficiency testing were treated with either Cleanascite HC or
chloroform. The lipid content was measured before and after treatment.
The total percentages of lipid removed ranged from 61 to 70% with
Cleanascite HC and from 60 to 62% with chloroform. The advantage of
Cleanascite HC over chloroform is based on the simplicity of the
procedure with Cleanascite HC without the environmental concerns
inherent in the use of chloroform. In 15 serum samples known to contain
antibodies to treponemal and nontreponemal syphilis antigens,
Cleanascite HC bound some immunoglobulin, but with only minimal loss of
reactivity in the serologic tests for syphilis. Cleanascite HC is
therefore an acceptable alternative to chloroform for lipid reduction
in human serum samples.
1071-412X/00/$04.00+0
Lipid Removal from Human Serum Samples
*
Corresponding author. Mailing address: Division of
AIDS, STD, and TB Laboratory Research, Centers for Disease Control and Prevention, 1600 Clifton Rd., Mail Stop D-13, Atlanta, GA 30333. Phone:
(404) 639-2874. Fax: (404) 639-3976. E-mail: ajc5{at}cdc.gov.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»